Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Connie M Sears

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
American Journal of Ophthalmology|March 1, 2022
Hearing Dysfunction After Treatment With Teprotumumab for Thyroid Eye DiseaseConnie M Sears, Amee D Azad, Linus Amarikwa, et al.
International Forum of Allergy & Rhinology|March 21, 2025
Outcomes of Acute Invasive Fungal Rhinosinusitis Patients Treated with Retrobulbar Amphotericin B Injections versus Orbital ExenterationJakob L Fischer, Nikitha Kosaraju, Katherine M Lucarelli, et al.
Ophthalmology|February 13, 2024
ReplyShreya A Shah, Linus Amarikwa, Connie M Sears, et al.
Ophthalmology|October 18, 2023
Teprotumumab-Related Adverse Events in Thyroid Eye Disease: A Multicenter StudyShreya A Shah, Linus Amarikwa, Connie M Sears, et al.
Ophthalmic Plastic and Reconstructive Surgery|September 12, 2022
Outcomes of Patients With Thyroid Eye Disease Partially Treated With TeprotumumabTiffany C Ho, Robi N Maamari, Andrea L Kossler, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
American Journal of Ophthalmology|March 1, 2022
Hearing Dysfunction After Treatment With Teprotumumab for Thyroid Eye DiseaseConnie M Sears, Amee D Azad, Linus Amarikwa, et al.
International Forum of Allergy & Rhinology|March 21, 2025
Outcomes of Acute Invasive Fungal Rhinosinusitis Patients Treated with Retrobulbar Amphotericin B Injections versus Orbital ExenterationJakob L Fischer, Nikitha Kosaraju, Katherine M Lucarelli, et al.
Ophthalmology|February 13, 2024
ReplyShreya A Shah, Linus Amarikwa, Connie M Sears, et al.
Ophthalmology|October 18, 2023
Teprotumumab-Related Adverse Events in Thyroid Eye Disease: A Multicenter StudyShreya A Shah, Linus Amarikwa, Connie M Sears, et al.
Ophthalmic Plastic and Reconstructive Surgery|September 12, 2022
Outcomes of Patients With Thyroid Eye Disease Partially Treated With TeprotumumabTiffany C Ho, Robi N Maamari, Andrea L Kossler, et al.
Pageof 2